FEB 08, 2021 5:04 AM PST

Fecal Transplants May Improve Cancer Treatment Efficacy

WRITTEN BY: Carmen Leitch

Humans carry around trillions of microbes, and the ones in our guts - the gut microbiome - play an essential role in our health. Researchers have been learning more about the many connections between human health, disease, and gut bacteria. Work has shown that these gut microbes can affect how medications are metabolized. Some research has suggested that the composition of the microbiome may be connected to how well cancer treatment works.

Image credit: Pixabay

Now scientists have determined that if immunotherapy is not working for a patient, it might work better if an alteration is made to their gut microbiome. This could be accomplished by transplanting feces from healthy donors to these patients (in a clinical setting). The findings have been reported in Science.

In this work, the investigators assessed advanced melanoma patients who had not responded to treatment with a type of immunotherapy called an immune checkpoint inhibitor. These drugs are supposed to work by releasing a brake that stops the immune system from attacking cancer cells.

The researchers created safe fecal transplants from volunteers with advanced melanoma who responded positively to an immune checkpoint inhibitor called pembrolizumab. These transplants were delivered (through colonoscopies) to advanced melanoma patients that had not responded to immune checkpoint inhibitor treatment. Six of fifteen patients that had not seen any effect from these drugs began to see their tumors shrink, or their disease stabilize after the transplant. There were some minor side effects associated with pembrolizumab, but four of the now-responsive patients have not shown disease progression for more than a year, and one has been responding partially for over two years.

"In recent years, immunotherapy drugs called PD-1 and PD-L1 inhibitors have benefited many patients with certain types of cancer, but we need new strategies to help patients whose cancers do not respond," said the study co-leader Giorgio Trinchieri, M.D., chief of the Laboratory of Integrative Cancer Immunology at the National Cancer Institute's (NCI's) Center for Cancer Research. "Our study is one of the first to demonstrate in patients that altering the composition of the gut microbiome can improve the response to immunotherapy. The data provide proof of concept that the gut microbiome can be a therapeutic target in cancer."

Trinchieri added that more research will be needed to figure out which bacteria enabled the patient to overcome the drug resistance, and exactly how that happened.

Previous work has indicated that changing the microbiome in a mouse model can improve how well immunotherapy works. The gut microbiome may be affecting tumor microenvironments, suggested Trinchieri.

The scientists also found that there were increased numbers of bacteria that are linked to T cell activation and immune checkpoint response in the patients whose diseases had stabilized or improved. There was also a reduction in the level of biomarkers that have been linked to immunotherapy resistance, and an increase in those linked to immunotherapy response.

The researchers are hopeful that these results will promote larger clinical trials to confirm the findings, identify other biomarkers, and find candidate patients.

"We expect that future studies will identify which groups of bacteria in the gut are capable of converting patients who do not respond to immunotherapy drugs into patients who do respond," said study co-first author Amiran Dzutsev, M.D., Ph.D., of NCI's Center for Cancer Research. "These could come from patients who have responded or from healthy donors. If researchers can identify which microorganisms are critical for the response to immunotherapy, then it may be possible to deliver these organisms directly to patients who need them, without requiring a fecal transplant," he added.

Sources: AAAS/Eurekalert! via NIH/National Cancer Institute, Science

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 08, 2021
Microbiology
Antibiotic Resistance Genes Can Come From Random DNA Sequences
JAN 08, 2021
Antibiotic Resistance Genes Can Come From Random DNA Sequences
Bacterial infections that can't be eliminated with standard drugs, caused by antibiotic-resistant bacteria, are consider ...
JAN 18, 2021
Microbiology
Bacteria in Sediment is Likely Accelerating Greenland's Meltdown
JAN 18, 2021
Bacteria in Sediment is Likely Accelerating Greenland's Meltdown
For decades, scientists have been sounding the alarm about rising carbon dioxide levels in our planet's atmosphere, and ...
JAN 23, 2021
Microbiology
Host Vouchering & How Can It Improve Pandemic Response
JAN 23, 2021
Host Vouchering & How Can It Improve Pandemic Response
About a year ago, I wrote about the virus that would come to be known as SARS-CoV-2 for the first time. And while we've ...
FEB 07, 2021
Microbiology
Positive Results From A Clinical Trial of an HIV Vaccine
FEB 07, 2021
Positive Results From A Clinical Trial of an HIV Vaccine
After years of effort, researchers are reporting that there were encouraging results from a phase 1 clinical trial which ...
MAR 01, 2021
Cell & Molecular Biology
Sulfur May've Been Essential to the Evolution of Multicellular Life
MAR 01, 2021
Sulfur May've Been Essential to the Evolution of Multicellular Life
We've heard a lot about how important carbon and water are to life, but sulfur? Researchers think that sulfur may have a ...
MAR 15, 2021
Microbiology
Scientists Trace the Evolutionary Path of a Hospital Superbug
MAR 15, 2021
Scientists Trace the Evolutionary Path of a Hospital Superbug
Antibiotic resistance was developing in bacteria earlier than we knew.
Loading Comments...